Novo Nordisk

Diabetic patients using Ozempic report severe side effects, including stomach paralysis and pancreatitis, CTV News reports. Jana Norman, a Type 2 diabetic, described her experience with Ozempic as a “roller-coaster ride.” She was prescribed the drug in 2019 to counteract weight gain...

Novo Nordisk and Eli Lilly and Co. (NYSE:LLY), manufacturers of diabetes drugs Ozempic and Mounjaro, are facing a lawsuit over claims of causing gastroparesis, CBS News reports. The lawsuit, filed by personal injury law firm Morgan & Morgan, alleges a “failure to warn” about the...

The demand for the weight-loss drug semaglutide, used by celebrities like Elon Musk and Jeremy Clarkson, is causing a national shortage in the U.K., putting the lives of diabetics at risk, The Daily Mail reports. Off-Label Prescribing Fuels Shortage: The drug, marketed as Ozempic and used for...

Actress Raven-Symoné has voiced her concerns about the misuse of the Type 2 diabetes drug Ozempic for weight loss purposes in Hollywood, PopCulture reports. “I think it’s very important we understand certain medications are made for certain people and to not take that away just for...

A recent trend on TikTok has users claiming that the popular medication Ozempic is causing saggy skin, particularly in the buttocks area. This phenomenon has been dubbed “Ozempic butt,” Yahoo Canada reports. The Claim TikTok user @jocelyngarcia3514 went viral for her claim that Ozempic...

Novo Nordisk (NYSE:NVO), the pharmaceutical giant behind popular semaglutide drugs like Ozempic, Rybelsus, and Wegovy, is making a significant legal push to prevent the sale of semaglutide knockoffs in the U.S., Rolling Stone reports. Legal Battle Against Knockoffs According to the lawsuits...

Swissmedic, the Swiss drugs regulator, has issued a warning against the purchase of drugs from unreliable sources, particularly from abroad, following reports of hospitalizations linked to counterfeit injectables of the diabetes medication Ozempic, Swissinfo reports. Counterfeit Ozempic and Health...

On Tuesday, the European Union’s drug regulator expanded its investigation into the risk of suicidal thoughts and self-injury among patients taking weight loss and diabetes medications, including those produced by Novo Nordisk (NASDAQ:NVO). The probe now encompasses about 150 reported cases...

  Shares of Novo Nordisk A/S (NYSE: NVO) are up over 3.6% on April 12. The immediate catalyst is the announcement of a $2.6 billion collaboration with Aspect Biosystems. But for investors who have been watching the stock, this is just the continuation of a larger trend for the Danish...

This weekend's Barron's examines the prospects for a British multinational telecommunications company. The prospects for an auto components supplier and the world leader in diabetes treatment are also examined. Other featured stories include a look at a luxury hotel chain poised for growth. "...

Novo Nordisk A/S (ADR) (NYSE: NVO) presented data at the American Diabetes Association on Monday and trusted the doctors in attendance to not share the confidential and market-moving data they just saw. As if that would actually happen in the modern day of smartphones and social media....

The three largest biotechs are set to share their latest quarterly results this week. Wall Street analysts are looking for solid to strong growth from all three. However, expectations are lower for many other biotech and pharmaceutical companies reporting this week. The three largest public...